Aggregated
48% success rate- Bullish
- 20
- Hold
- 2
- Bearish
- 4
Barclays
A Barclays analyst with 33 tracked ratings across 29 distinct tickers has a 47.7% success rate on the captured sample, including 8 bullish ratings and 1 hold rating.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| NUVL | 2025-10-31 | buy | $112.00 | Aggregated |
| GILD | 2024-11-07 | sell | $95.00 | Aggregated |
| GILDGILEAD SCIENCES, INC. | 2024-11-07 | unknown | $95.00 | Aggregated |
| BIIB | 2024-10-31 | buy | $180.00 | Aggregated |
| BIIBBIOGEN INC | 2024-10-31 | unknown | $180.00 | Aggregated |
| LLY | 2024-10-31 | buy | $975.00 | Aggregated |
| LLYLILLY(ELI) & CO | 2024-10-31 | unknown | $975.00 | Aggregated |
| REGN | 2024-10-23 | buy | $1080.00 | Aggregated |
| REGNREGENERON PHARMACEUTICALS, INC. | 2024-10-23 | unknown | $1080.00 | Aggregated |
| ABBV | 2024-10-07 | buy | $212.00 | Aggregated |
| ABBVABBVIE INC | 2024-10-07 | unknown | $212.00 | Aggregated |
| AMGN | 2024-10-07 | hold | $315.00 | Aggregated |
| AMGNAMGEN INC. | 2024-10-07 | hold | $315.00 | Aggregated |
| BMY | 2024-10-07 | sell | $43.00 | Aggregated |
| BMYBRISTOL-MYERS SQUIBB CO. | 2024-10-07 | unknown | $43.00 | Aggregated |
| MRK | 2024-10-07 | buy | $140.00 | Aggregated |
| MRKMERCK & CO INC | 2024-10-07 | unknown | $140.00 | Aggregated |
| TVTX | 2024-10-01 | buy | $18.00 | Aggregated |
| TVTXTRAVERE THERAPEUTICS INC | 2024-10-01 | unknown | $18.00 | Aggregated |
| NUVL | 2024-08-29 | buy | $100.00 | Aggregated |
| NUVLNUVALENT INC - ORDINARY SHARES - CLASS A | 2024-08-29 | unknown | $100.00 | Aggregated |
| VOR | 2024-08-14 | sell | $3.00 | Aggregated |
| VORVOR BIOPHARMA INC | 2024-08-14 | unknown | $3.00 | Aggregated |
| PFE | 2024-07-31 | buy | $32.00 | Aggregated |
| PFEPFIZER INC. | 2024-07-31 | unknown | $32.00 | Aggregated |
| BRNS | 2024-06-13 | buy | $3.00 | Aggregated |
| BRNSBARINTHUS BIOTHERAPEUTICS PLC. - ADR | 2024-06-13 | unknown | $3.00 | Aggregated |
| GERN | 2024-06-11 | buy | $9.00 | Aggregated |
| GERNGERON CORP. | 2024-06-11 | unknown | $9.00 | Aggregated |
| SKIL | 2024-04-16 | buy | $20.00 | Aggregated |
| SKILSKILLSOFT CORP. - ORDINARY SHARES - CLASS A | 2024-04-16 | unknown | $20.00 | Aggregated |
| ACLX | 2024-02-29 | buy | $73.00 | Aggregated |
| ACLXARCELLX INC | 2024-02-29 | unknown | $73.00 | Aggregated |
| NBIX | 2024-01-23 | buy | $150.00 | Aggregated |
| NBIXNEUROCRINE BIOSCIENCES, INC. | 2024-01-23 | unknown | $150.00 | Aggregated |
| ALLK | 2024-01-17 | sell | $1.00 | Aggregated |
| ALLKALLAKOS INC | 2024-01-17 | unknown | $1.00 | Aggregated |
| SKIL | 2023-12-06 | buy | $30.00 | Aggregated |
| SKIL | 2023-08-18 | buy | $2.50 | Aggregated |
| RETA | 2023-08-01 | buy | $172.00 | Aggregated |
| RETA- | 2023-08-01 | unknown | $172.00 | Aggregated |
| SKIL | 2023-06-07 | buy | $2.90 | Aggregated |
| SKIL | 2023-04-12 | buy | $3.50 | Aggregated |
| GOSS | 2023-03-21 | buy | $1.50 | Aggregated |
| GOSSGOSSAMER BIO INC | 2023-03-21 | unknown | $1.50 | Aggregated |
| APLT | 2022-08-16 | buy | $2.25 | Aggregated |
| APLTAPPLIED THERAPEUTICS INC | 2022-08-16 | unknown | $2.25 | Aggregated |
| ALEC | 2022-05-11 | buy | $14.00 | Aggregated |
| ALECALECTOR INC | 2022-05-11 | unknown | $14.00 | Aggregated |
| MTEM | 2022-03-30 | buy | $4.50 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| NUVL | 3 | 2025-10-31 | Aggregated |
| GILD | 2 | 2024-11-07 | Aggregated |
| GILDGILEAD SCIENCES, INC. | 1 | 2024-11-07 | Aggregated |
| BIIB | 2 | 2024-10-31 | Aggregated |
| BIIBBIOGEN INC | 1 | 2024-10-31 | Aggregated |
| LLY | 2 | 2024-10-31 | Aggregated |
| LLYLILLY(ELI) & CO | 1 | 2024-10-31 | Aggregated |
| REGN | 2 | 2024-10-23 | Aggregated |
| REGNREGENERON PHARMACEUTICALS, INC. | 1 | 2024-10-23 | Aggregated |
| ABBV | 2 | 2024-10-07 | Aggregated |
| ABBVABBVIE INC | 1 | 2024-10-07 | Aggregated |
| AMGN | 1 | 2024-10-07 | Aggregated |
| AMGNAMGEN INC. | 1 | 2024-10-07 | Aggregated |
| BMY | 2 | 2024-10-07 | Aggregated |
| BMYBRISTOL-MYERS SQUIBB CO. | 1 | 2024-10-07 | Aggregated |
| MRK | 2 | 2024-10-07 | Aggregated |
| MRKMERCK & CO INC | 1 | 2024-10-07 | Aggregated |
| TVTX | 2 | 2024-10-01 | Aggregated |
| TVTXTRAVERE THERAPEUTICS INC | 1 | 2024-10-01 | Aggregated |
| NUVLNUVALENT INC - ORDINARY SHARES - CLASS A | 1 | 2024-08-29 | Aggregated |
| VOR | 3 | 2024-08-14 | Aggregated |
| VORVOR BIOPHARMA INC | 1 | 2024-08-14 | Aggregated |
| PFE | 2 | 2024-07-31 | Aggregated |
| PFEPFIZER INC. | 1 | 2024-07-31 | Aggregated |
| BRNS | 2 | 2024-06-13 | Aggregated |
| BRNSBARINTHUS BIOTHERAPEUTICS PLC. - ADR | 1 | 2024-06-13 | Aggregated |
| GERN | 3 | 2024-06-11 | Aggregated |
| GERNGERON CORP. | 1 | 2024-06-11 | Aggregated |
| SKIL | 7 | 2024-04-16 | Aggregated |
| SKILSKILLSOFT CORP. - ORDINARY SHARES - CLASS A | 1 | 2024-04-16 | Aggregated |
| ACLX | 2 | 2024-02-29 | Aggregated |
| ACLXARCELLX INC | 1 | 2024-02-29 | Aggregated |
| NBIX | 2 | 2024-01-23 | Aggregated |
| NBIXNEUROCRINE BIOSCIENCES, INC. | 1 | 2024-01-23 | Aggregated |
| ALLK | 2 | 2024-01-17 | Aggregated |
| ALLKALLAKOS INC | 1 | 2024-01-17 | Aggregated |
| RETA | 2 | 2023-08-01 | Aggregated |
| RETA- | 1 | 2023-08-01 | Aggregated |
| GOSS | 2 | 2023-03-21 | Aggregated |
| GOSSGOSSAMER BIO INC | 1 | 2023-03-21 | Aggregated |
| APLT | 2 | 2022-08-16 | Aggregated |
| APLTAPPLIED THERAPEUTICS INC | 1 | 2022-08-16 | Aggregated |
| ALEC | 2 | 2022-05-11 | Aggregated |
| ALECALECTOR INC | 1 | 2022-05-11 | Aggregated |
| MTEM | 2 | 2022-03-30 | Aggregated |
| MTEMMOLECULAR TEMPLATES INC | 1 | 2022-03-30 | Aggregated |
| PAYC | 2 | 2022-01-20 | Aggregated |
| PAYCPAYCOM SOFTWARE INC | 1 | 2022-01-20 | Aggregated |
| CYTK | 2 | 2021-07-20 | Aggregated |
| CYTKCYTOKINETICS INC | 1 | 2021-07-20 | Aggregated |